Inhaled epinephrine for anaphylaxis: Time for another look?

Shaker, Marcus S; Golden, David B K; Lieberman, Jay A; Greenhawt, Matthew; Lee, Michael W

Shaker, Marcus S; Golden, David B K; Lieberman, Jay A; Greenhawt, Matthew; Lee, Michael W.

Afiliação

Shaker MS; Departments of Medicine and Pediatrics, Dartmouth Geisel School of Medicine, Hanover, New Hampshire; Section of Allergy and Immunology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. Electronic address: Marcus.shaker@dartmouth.edu.
Golden DBK; Johns Hopkins University School of Medicine, Baltimore, Maryland.
Lieberman JA; Department of Pediatrics, The University of Tennessee Health Sciences Center, Memphis, Tennessee.
Greenhawt M; Section of Allergy and Clinical Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado.
Lee MW; Department of Medical Education, Dartmouth Geisel School of Medicine, Hanover, New Hampshire.

Ann Allergy Asthma Immunol ; 132(3): 267-269, 2024 Mar.

Article em En | MEDLINE | ID: mdl-38072310

Assuntos

Anafilaxia; Humanos; Anafilaxia/tratamento farmacológico; Epinefrina/uso terapêutico; Administração por Inalação

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anafilaxia Limite: Humans Idioma: En Revista: Ann Allergy Asthma Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google